SCHEMBL29965169

SCHEMBL29965169

CC(C)N1CCN(c2ccc(-c3cc(-c4ccc5c(c4)C4(CC4)CNC5=O)c(N)nc3F)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.38
▸ ALK Q9UM73 6/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.37
▸ TGFBR1 P36897 5/20 0.35
▸ ACVR1 Q04771 5/20 0.35
▸ BMPR1B O00238 2/20 0.35
▸ BMPR1A P36894 2/20 0.35
▸ ACVRL1 P37023 2/20 0.35
▸ ACVR1B P36896 1/20 0.35
▸ TNIK Q9UKE5 1/20 0.35
▸ CDK4 P11802 2/20 0.35
▸ CCND1 P24385 2/20 0.35
▸ CDK2 P24941 2/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CCND3 P30281 1/20 0.34
▸ TTK P33981 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ CCNH P51946 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31079426 0.93 FYN (0.37) FYNALKHRH3TGFBR1ACVR1
SCHEMBL27159814 0.87 ALK (0.37) FYNALKHRH3TGFBR1ACVR1
SCHEMBL29964957 0.83 MAPK1 (0.42) FYNALKHRH3TGFBR1ACVR1
SCHEMBL31079351 0.82 TDP2 (0.43) FYNALKHRH3TGFBR1ACVR1
SCHEMBL29964557 0.81 MAPKAPK2 (0.41) FYNALKHRH3TGFBR1ACVR1
SCHEMBL29964634 0.81 MAPK1 (0.41) FYNALKHRH3TGFBR1ACVR1
SCHEMBL29964628 0.80 FYN (0.40) FYNALKHRH3TGFBR1ACVR1
SCHEMBL31079124 0.80 ACVR1 (0.39) FYNALKHRH3TGFBR1ACVR1
SCHEMBL31079283 0.79 ADORA2A (0.40) TGFBR1ACVR1CDK4CCND1CDK2
SCHEMBL29964599 0.77 ALK (0.38) FYNALKHRH3TGFBR1ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 — — US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 FYN 1364/4885ALK 1520/4885HRH3 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback